<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>HPLC methods for clinical pharmaceutical analysis</title>
    <subTitle>a user's guide</subTitle>
  </titleInfo>
  <name type="personal">
    <namePart>Mascher, Hermann.</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">gw</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Weinheim</placeTerm>
    </place>
    <publisher>Wiley-VCH</publisher>
    <dateIssued>c2012</dateIssued>
    <dateIssued encoding="marc">2012</dateIssued>
    <edition>1st ed.</edition>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>ix, 247 p. : ill. ; 25 cm.</extent>
  </physicalDescription>
  <tableOfContents>1.Introduction -- 1.1.First Question: Determination of Ibuprofen in Plasma -- 1.2.Second Question: Determination of Tryptophan in Urine -- 1.3.Third Question: Determination of Paclitaxel in Tissue -- 2.Planning of Analyses -- 2.1.Introduction -- 2.2.Limit of Detection (LOD) and Determination (LLOQ) -- 2.3.Detectors -- 2.4.Structure of the Analyte -- 2.5.Solubility of an Analyte -- 2.6.Selection of the Detector -- 3.Sample Preparation -- 3.1.Dilution -- 3.2.Protein Precipitation, Overview -- 3.3.Extraction -- 4.HPLC Separation -- 4.1.HPLC Pumps -- 4.2.Degasser -- 4.3.Injector -- 4.4.HPLC Columns -- 5.Detection -- 5.1.Detection in the Pharmaceutical/Bioanalytical Area -- 5.2.Detection in the "Clinical Area" (Therapy Control/Compliance) -- 6.Chemical Derivatization for Detection Enhancement -- 7.Validation Concepts -- 7.1.Introduction -- 7.2.Realization of the FDA Guideline --  8.Practical Hints Concerning Stability, Destruction and Degradation Products -- 9.Metabolites -- 10.Internal Standards -- 11.Case Studies with Intensive Discussion for Each Substance -- 11.1.Acetylcarnitine in Plasma -- 11.2.Acetylcysteine in Plasma -- 11.3.Acyclovir in Plasma and Urine -- 11.4.Caffeine in Plasma -- 11.5.Diazepam in Plasma -- 11.6.Diclofenac in Plasma -- 11.7.Dihydralazine in Plasma -- 11.8.Duramycin (Moli1901) in Plasma -- 11.9.Fluticasone Propionate in Plasma -- 11.10.Hydroxytriamterene Sulfate and Triamterene in Plasma and Urine -- 11.11.Ibuprofen in Plasma (also Enantiomeric Separation) -- 11.12.Minocycline in Plasma -- 11.13.Norfloxacine in Plasma and Urine -- 11.14.Paclitaxel in Plasma, Urine and Tissue -- 11.15.Paracetamol (Acetaminophen) in Plasma -- 11.16.Pimelic Acid in Plasma and Urine -- 11.17.8-Prenylnaringenin in Plasma and Different Types of Tissues -- 11.18.Silibinin in Plasma -- 11.19.Valnemulin in Plasma, Different Tissue Types and in Animal Feed -- 11.20.Vitamin B1 (Total Thiamine) in Plasma -- Table 11.1 Recommended books -- Table 11.2 Properties of substances -- Appendix -- Short Description of Determination for about 100 Substances -- Substances listed in the Appendix.</tableOfContents>
  <note type="statement of responsibility">Hermann Mascher.</note>
  <note>Includes bibliographical references and index.</note>
  <subject authority="lcsh">
    <topic>High performance liquid chromatography</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Drugs</topic>
    <topic>Analysis</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Pharmaceutical technology</topic>
  </subject>
  <classification authority="lcc">RS189 .M36 2012</classification>
  <classification authority="ddc">615.1901 MAH</classification>
  <identifier type="isbn">9783527331291</identifier>
  <identifier type="lccn">2012392592</identifier>
  <identifier type="uri">http://www.loc.gov/catdir/enhancements/fy1210/2012392592-b.html</identifier>
  <identifier type="uri">http://www.loc.gov/catdir/enhancements/fy1210/2012392592-d.html</identifier>
  <identifier type="uri">http://www.loc.gov/catdir/enhancements/fy1210/2012392592-t.html</identifier>
  <location>
    <url displayLabel="Contributor biographical information">http://www.loc.gov/catdir/enhancements/fy1210/2012392592-b.html</url>
  </location>
  <location>
    <url displayLabel="Publisher description">http://www.loc.gov/catdir/enhancements/fy1210/2012392592-d.html</url>
  </location>
  <location>
    <url displayLabel="Table of contents only">http://www.loc.gov/catdir/enhancements/fy1210/2012392592-t.html</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">BTCTA</recordContentSource>
    <recordCreationDate encoding="marc">120430</recordCreationDate>
    <recordChangeDate encoding="iso8601">20150121172301.0</recordChangeDate>
    <recordIdentifier source="BD-DhUL">17278804</recordIdentifier>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
